Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets kr 3064.88 kr 102.25 kr 9202.47
  • Free AirMail shipping
60 tablets kr 1634.35 kr 109.06 kr 6543.88
  • Free AirMail shipping
30 tablets kr 612.84 kr 115.88 kr 3476.28
  • Free AirMail shipping
20 tablets kr 272.34 kr 122.69 kr 2453.74
  • Free AirMail shipping
10 tablets kr 136.30 kr 1363.04
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets kr 1224.32 kr 122.70 kr 11043.04
  • Free AirMail shipping
60 tablets kr 611.82 kr 126.11 kr 7566.42
  • Free AirMail shipping
30 tablets kr 203.83 kr 129.51 kr 3885.29
  • Free AirMail shipping
20 tablets kr 67.83 kr 132.91 kr 2658.25
  • Free AirMail shipping
10 tablets kr 136.30 kr 1363.04
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets kr 1531.08 kr 146.56 kr 13190.36
  • Free AirMail shipping
60 tablets kr 816.32 kr 149.97 kr 8997.97
  • Free AirMail shipping
30 tablets kr 306.08 kr 153.37 kr 4601.07
  • Free AirMail shipping
20 tablets kr 136.00 kr 156.77 kr 3135.43
  • Free AirMail shipping
10 tablets kr 163.57 kr 1635.72
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.